PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 321 results · Data & Publications  · Clear
🔒 Subscribers only
AUTH/3121/11/18
Data & Publications Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Biogen Idec
A hospital doctor complained about an Imraldi (adalimumab) mailing sent by Biogen Idec to their home address which required a signature, meaning they had to collect it from a post office five miles…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3099/9/18
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Allergan
The PMCPA Director opened a complaint (Paragraph 5.1) after a BMJ paper (Goldacre et al, 12 Sept 2018) ranked sponsors’ compliance with posting results to the EU Clinical Trials Register (EUCTR) …
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3074/9/18
Data & Publications Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Director v AbbVie (AUTH/3074/9/18)
A complaint was brought by the Director against AbbVie.The subject matter related to clinical trial disclosure.The case was assessed under the ABPI Code year 2016.
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3072/9/18
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Servier
A matter relating to clinical trial disclosure involving Servier was considered following a complaint by the Director.The case was assessed under the ABPI Code of Practice 2016.The PMCPA determined…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3079/9/18
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Pfizer
The PMCPA Director opened a complaint (Paragraph 5.1) after a BMJ paper (Goldacre et al, 12 Sept 2018) assessed whether sponsors posted due results on the EU Clinical Trials Register (EUCTR) by the…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3084/9/18
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Boehringer Ingelheim
The PMCPA Director took up a complaint (Paragraph 5.1) after a BMJ paper (Goldacre et al, 12 Sept 2018) assessed whether sponsors posted due results to the EU Clinical Trials Register (EUCTR) by th…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3087/9/18
Data & Publications Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
The PMCPA Director opened a complaint (Paragraph 5.1) after a BMJ paper reported that GlaxoSmithKline (GSK) had 33 “due trials” without results on EUCTR (reported disclosure rate 88.7%). GSK …
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3125/11/18
Data & Publications Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Takeda v Merck Sharp & Dohme
Takeda (Vipidia/alogliptin) raised inter-company dialogue with Merck Sharp & Dohme (Januvia/sitagliptin) about a “Sitagliptin Information Pack” that mentioned alogliptin and displayed the i…
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3018/2/18
Data & Publications Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Tesaro
Tesaro UK identified (via an internal email in Feb 2018) that seven hard-copy promotional items for Zejula (niraparib) might have been distributed to the field team before certification of their fi…
Clauses: 9.1
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3015/1/18
Data & Publications Upheld 🏥 Other ▶ Video 🎙 Podcast
Daiichi-Sankyo voluntary admission
Daiichi-Sankyo UK discovered (and voluntarily admitted) that three medical staff acted as nominated signatories before their names and qualifications were notified in advance to the MHRA and the PM…
Clauses: 9.1
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3016/1/18
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Takeda
A consultant haematologist made a complaint against Takeda.The allegation related to religious discrimination.The case was considered under the ABPI Code of Practice (Applicable Code year: 2016).
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/2938/2/17
Data & Publications Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi v Novo Nordisk
Sanofi UK complained about a Novo Nordisk promotional leavepiece for Tresiba (insulin degludec) (ref UK/TB/1214/0302(4)).Page 3 headline claim: “Tresiba provides 75% less variability in glucose-l…
Clauses: 3.2,4.1,4.2
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2965/8/17
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Anonymous employee complaint about Biogen bonus scheme (No breach on appeal)
An anonymous, contactable complainant (a current employee) alleged that over five years Biogen field-based employees (including three named individuals) received “huge bonuses” and incentives.T…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2959/5/17
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Patient recruitment ‘finder’s fee’ for market research email (Bayer)
A head of medicines management at a health board complained about an email sent by a market research recruitment agency to a hospital consultant/cardiologist.The email subject referenced a “Finde…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2953/4/17
Data & Publications Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Dr Falk journal ad for Salofalk Granules
Tillotts Pharma UK Limited complained about a journal advertisement (ref DrF 17/041) for Salofalk (mesalazine, prolonged release) Granules placed by Dr Falk Pharma UK Ltd and published in Frontline…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2948/3/17
Data & Publications Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Novo Nordisk breached ABPI Code over misleading Tresiba cost comparison email (AUTH/2948/3/17)
A general practitioner complained about a promotional email for Tresiba (insulin degludec) sent by Novo Nordisk (ref UK/TB/1116/0498).The email opened with claims including “Get HbA1c DOWN with C…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2975/9/17
Data & Publications Upheld 🏥 Other ▶ Video 🎙 Podcast
A Menarini
A Menarini made its initial, timely Disclosure UK submission for 2016 transfers of value on 29 March 2017.After that submission, it received additional information from corporate/R&D colleagues…
Clauses: 26.1
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2968/8/17
Data & Publications Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Bausch & Lomb
A letter in The Pharmaceutical Journal (July 2017) criticised Bausch & Lomb’s claims that Emerade (adrenaline auto-injector) had a 30-month shelf-life versus 18 months for EpiPen.The complain…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2970/8/17
Data & Publications Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Janssen promotional email about Invokana rebates
An anonymous, non-contactable complainant raised concerns about a Janssen regional business manager (RBM) and an email promoting/relating to Invokana (canagliflozin) for type 2 diabetes.The complai…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2984/10/17
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Astellas UK
A hospital doctor alleged Astellas UK inappropriately awarded research funding (~£250,000) in 2009 in association with use of Advagraf (tacrolimus) in a renal transplant protocol (Advagraf de novo…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/3001/12/17
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Sunovion
A matter was raised by the PMCPA Director concerning clinical trial disclosure relating to Latuda.The complaint was received on 20 December 2017 under the 2016 ABPI Code.
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/3007/12/17
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Vifor Fresenius
The PMCPA Director reviewed a matter relating to clinical trial disclosure for Velphoro involving Vifor Fresenius.The review was assessed under the ABPI Code of Practice (Applicable Code year: 2016…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/3006/12/17
Data & Publications Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
PMCPA AUTH/3006/12/17
A complaint was brought by the PMCPA Director against Lilly.The subject matter related to clinical trial disclosure for Trulicity.Complaint received: 20 December 2017.Case completed: 06 March 2018.
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/3004/12/17
Data & Publications Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Gilead
The PMCPA Director raised a case concerning clinical trial disclosure relating to Sovaldi.The case was considered under the ABPI Code of Practice (Applicable Code year: 2016).
Clauses: NONE
2017 🔒 Subscribe
← Prev 1 2 3 4 5 6 Next → Page 3 of 14 — 321 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews